Rochester Regional Health’s wholly-owned subsidiary, ACM Global Laboratories, recently acquired ABS Laboratories in Hertfordshire, England, which focuses on bioanalytical services.
ABS Laboratories specializes in complex assay method development and validation for the quantification of drugs, metabolites and biomarkers in biological samples for preclinical and clinical trials. The organization has experience in supporting pharmaceutical companies, academic institutions and government agencies in the U.S. and U.K.
“Strategic acquisitions of organizations on the forefront of research and testing, like ABS Laboratories, are critical to RRH’s overall growth strategy as the health care industry continues to evolve,” said Eric Bieber, president and CEO of Rochester Regional Health. “We continue to pursue partnerships with best-in-breed laboratories that are pioneering testing to drive innovation in the pharmaceutical laboratory market.”